Trial · NCT07894068
IMB-Guided Health Education Intervention for Medication Adherence and Blood Pressure Control in Non-adherent Hypertensive Patients
NCT07894068, Not applicable, Recruiting, Bahir Dar University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. IMB-Guided Health Education Intervention for Medication Adherence and Blood Pressure Control in Non-adherent Hypertensive Patients. Trials, record NCT07894068. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07894068
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- IMB-Guided Health Education Intervention for Medication Adherence and Blood Pressure Control in Non-adherent Hypertensive Patients
- NCT number
- NCT07894068
- Status
- Recruiting
- Phases
- Not applicable
- Enrollment
- 230 participants, estimated
- Lead sponsor
- Bahir Dar University
- Conditions
- Hypertension
- Interventions
- IMB Model-Guided Health Education Intervention, Usual Care
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number and proportion of participants adherent to antihypertensive medication, assessed using the four-item Morisky-Green-Levine Medication Adherence Scale | Baseline and 4 months after the start of the intervention. | Medication adherence will be assessed using the four-item Morisky-Green-Levine Medication Adherence Scale. Each "Yes" response indicating non-adherent behavior will be scored 1, and each "No" response will be scored 0, yielding a total score ranging from 0 to 4. Participants scoring 0-1 will be classified as adherent, whereas those scoring 2-4 will be classified as non-adherent. The number and proportion of participants classified as adherent will be reported separately for the intervention and usual-care control groups. |
| Secondary | Number and Proportion of participants achieving blood pressure control based on systolic and diastolic blood pressure measurements | Baseline and 4 months after the start of the intervention. | Blood pressure will be measured using a validated automated digital sphygmomanometer. Participants will sit quietly for at least 5 minutes before measurement, with their back supported, feet flat on the floor, and arm supported at heart level. Measurements will be taken on the right arm using an appropriately sized cuff. Three readings will be obtained at 1-2-minute intervals, and the average of the last two readings will be used for analysis. Participants will be instructed to avoid caffeine, smoking, and physical activity for at least 30 minutes before measurement. Blood pressure control will be defined as systolic blood pressure below 140 mmHg and diastolic blood pressure below 90 mmHg. The number and proportion of participants achieving blood pressure control will be reported separately for the intervention and usual-care control groups. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07894068
GET https://conductscience.org/api/trials/v1/NCT07894068/registered